About John Strider
Form D filings for Fuse Oncology from 2022 to 2023 list John Strider as executive officer.
John Strider first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name John Strider in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Strider works with at each company, as listed on that company's latest Form D.
Fuse Oncology, Inc. · Form D, Apr 21, 2023
JM
John Miller
Director
JB
Jay Brennan
Director
BS
Benjamin Sintay
Executive officer
JB
James Bauler
Chief Executive Officer and director
DW
David Wiant
Executive officer